Top Markets
#1 Wrapped STX (Velar) Wrapped STX (Velar) +52.39%
#2 Pons Pons +47.46%
#3 TENDIES TENDIES +46.80%
#4 PondCoin PondCoin +43.65%
#5 Magma Finance Magma Finance +34.04%
#6 StonkBroker StonkBroker +31.98%
#7 Purr Purr +30.11%
#8 Starpower Starpower +29.64%
#9 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +27.14%
#10 SkyAI SkyAI +26.28%
Coin of the day
Wrapped STX (Velar) Wrapped STX (Velar)
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Muromachi Chemicals Inc. Muromachi Chemicals Inc.

Muromachi Chemicals Inc.

4885
Pozycja w akcjach #28995
Muromachi Chemicals Inc. plans, produces, and distributes pharmaceuticals,... Muromachi Chemicals Inc. plans, produces, and distributes pharmaceuticals, health foods, and chemicals in Japan. It offers active pharmaceutical ingredients and intermediate synthesis products; commissioned processing services for pharmaceuticals; and commissioned synthesis services, including GLP analysis, storage, stability testing, and repurification of radioisotopes. The company also provides traditional tablets; jelly; and non-alcoholic beverage products. In addition, it offers ion-exchange resins; separation membranes; water-treatment products; and contract processing services. Further, it provides functional adhesives; product contamination removal and dust removal mats, and antistatic products for use in the electronics industry; and engages in the commissioned manufacturing and processing of functional pastes. The company was founded in 1917 and is headquartered in Omuta, Japan.
Cena akcji
$5.83
Kapitalizacja rynkowa
$23.48M
Zmiana (1 dzień)
-1.54%
Zmiana (1 rok)
14.65%
Kraj
JP
Handel Muromachi Chemicals Inc. (4885)

Kategoria

Healthcare
Zyski dla Muromachi Chemicals Inc. (4885)
Zyski w 2026 TTM: 0
Według najnowszych raportów finansowych Muromachi Chemicals Inc., obecny zysk firmy wynosi 0. W roku 2026 firma osiągnęła zysk w wysokości 0, równa się zysku z roku 2026, który wynosił 0. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy Muromachi Chemicals Inc. od 2026 do 2026
Zyski na koniec każdego roku
Rok Zyski Zmień
Za mało danych dla podanych dat.
Zyski podobnych firm lub konkurentów
Firma Zyski Różnica w zyskach Kraj
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
$1.35B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
- -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
- -
FR
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
$26.37M -
US
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
- -
IT